Entity type
Individual
Filer Snapshot
Bridget A. Martell
CIK 0001629627. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
9
Latest filing
03 Nov 2023
Industry
n/a
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: Forms 3/4/5 owner position for ALGS. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
ALGS
25 Jun 2026
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View source filing
3/A filed on 03 Nov 2023 for CIK 0001629627.
- Business address
- C/O Point Biopharma Global Inc., 4850 West 78 Th Street, Indianapolis, IN, 46268
Filer intelligence
What SEC filings say about Bridget A. Martell
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Forms 3/4/5 show insider context for ALGS.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Forms 3/4/5 insider context
ALGS
25 Jun 2026
DCTH
13 May 2026
ACHV
06 Jun 2025
ADXS
18 Oct 2023
Latest update
What changed recently for Bridget A. Martell
Latest ownership report period: 25 Jun 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
29 Jun 2026
Page type
Ownership filings
Latest period
25 Jun 2026
Ownership context was refreshed from SEC Forms 3/4/5 filed on 29 Jun 2026.
SEC filing record
CIK 0001629627 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
9
First seen
18 Nov 2021
Latest filing
03 Nov 2023
Entity
Individual
Observed form types
3
3/A
4
CIK-linked evidence first
Latest Filings
Showing the latest 9 of 9 SEC filings for Bridget A. Martell.
3/A
3/A filing
- Filing date
- 03 Nov 2023
- Reporting date
- 18 Oct 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 21 Jul 2023
- Reporting date
- 20 Jul 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 14 Jun 2023
- Reporting date
- 13 Jun 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
3 filing
- Filing date
- 14 Jun 2023
- Reporting date
- 12 Jun 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 09 Jun 2023
- Reporting date
- 07 Jun 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Jun 2022
- Reporting date
- 23 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 01 Jun 2022
- Reporting date
- 31 May 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Nov 2021
- Reporting date
- 16 Nov 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
3 filing
- Filing date
- 18 Nov 2021
- Reporting date
- 16 Nov 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing